BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 18422964)

  • 1. Autologous bone marrow cell infusion therapy for liver cirrhosis.
    Sakaida I
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1349-53. PubMed ID: 18422964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lesson from the GFP/CCl4 model--translational research project: the development of cell therapy using autologous bone marrow cells in patients with liver cirrhosis.
    Terai S; Sakaida I; Nishina H; Okita K
    J Hepatobiliary Pancreat Surg; 2005; 12(3):203-7. PubMed ID: 15995808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autologous bone marrow cell infusion therapy for liver cirrhosis--now and future].
    Sakaida I
    Rinsho Byori; 2011 Dec; 59(12):1092-8. PubMed ID: 22338911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor 2 facilitates the differentiation of transplanted bone marrow cells into hepatocytes.
    Ishikawa T; Terai S; Urata Y; Marumoto Y; Aoyama K; Sakaida I; Murata T; Nishina H; Shinoda K; Uchimura S; Hamamoto Y; Okita K
    Cell Tissue Res; 2006 Feb; 323(2):221-31. PubMed ID: 16228231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone-marrow-derived cells cultured in serum-free medium reduce liver fibrosis and improve liver function in carbon-tetrachloride-treated cirrhotic mice.
    Iwamoto T; Terai S; Hisanaga T; Takami T; Yamamoto N; Watanabe S; Sakaida I
    Cell Tissue Res; 2013 Mar; 351(3):487-95. PubMed ID: 23183782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous bone marrow cell infusions suppress tumor initiation in hepatocarcinogenic mice with liver cirrhosis.
    Maeda M; Takami T; Terai S; Sakaida I
    J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2():104-11. PubMed ID: 22320927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of cell therapy using autologous bone marrow cells for liver cirrhosis.
    Sakaida I; Terai S; Nishina H; Okita K
    Med Mol Morphol; 2005 Dec; 38(4):197-202. PubMed ID: 16378227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of fibroblast growth factor 2 in combination with bone marrow transplantation synergistically improves carbon-tetrachloride-induced liver fibrosis in mice.
    Ishikawa T; Terai S; Urata Y; Marumoto Y; Aoyama K; Murata T; Mizunaga Y; Yamamoto N; Nishina H; Shinoda K; Sakaida I
    Cell Tissue Res; 2007 Mar; 327(3):463-70. PubMed ID: 17093919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplantation of urokinase-type plasminogen activator gene-modified bone marrow-derived liver stem cells reduces liver fibrosis in rats.
    Sun C; Li DG; Chen YW; Chen YW; Wang BC; Sun QL; Lu HM
    J Gene Med; 2008 Aug; 10(8):855-66. PubMed ID: 18481824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced therapies using autologous bone marrow cells for chronic liver disease.
    Takami T; Terai S; Sakaida I
    Discov Med; 2012 Jul; 14(74):7-12. PubMed ID: 22846198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel findings for the development of drug therapy for various liver diseases: Current state and future prospects for our liver regeneration therapy using autologous bone marrow cells for decompensated liver cirrhosis patients.
    Takami T; Terai S; Sakaida I
    J Pharmacol Sci; 2011; 115(3):274-8. PubMed ID: 21350310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice.
    Higashiyama R; Moro T; Nakao S; Mikami K; Fukumitsu H; Ueda Y; Ikeda K; Adachi E; Bou-Gharios G; Okazaki I; Inagaki Y
    Gastroenterology; 2009 Oct; 137(4):1459-66.e1. PubMed ID: 19596008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular signature associated with plasticity of bone marrow cell under persistent liver damage by self-organizing-map-based gene expression.
    Omori K; Terai S; Ishikawa T; Aoyama K; Sakaida I; Nishina H; Shinoda K; Uchimura S; Hamamoto Y; Okita K
    FEBS Lett; 2004 Dec; 578(1-2):10-20. PubMed ID: 15581608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance and therapeutic potential of endothelial progenitor cell transplantation in a cirrhotic liver rat model.
    Nakamura T; Torimura T; Sakamoto M; Hashimoto O; Taniguchi E; Inoue K; Sakata R; Kumashiro R; Murohara T; Ueno T; Sata M
    Gastroenterology; 2007 Jul; 133(1):91-107.e1. PubMed ID: 17631135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of galectin-3 expression and liver fibrosis after cell therapy in a mouse model of cirrhosis.
    de Oliveira SA; de Freitas Souza BS; Sá Barreto EP; Kaneto CM; Neto HA; Azevedo CM; Guimarães ET; de Freitas LA; Ribeiro-Dos-Santos R; Soares MB
    Cytotherapy; 2012 Mar; 14(3):339-49. PubMed ID: 22149185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of autologous bone marrow stem cell transplantation through hepatic artery for the treatment of chronic liver failure: a preliminary study.
    Khan AA; Parveen N; Mahaboob VS; Rajendraprasad A; Ravindraprakash HR; Venkateswarlu J; Rao SG; Narusu ML; Khaja MN; Pramila R; Habeeb A; Habibullah CM
    Transplant Proc; 2008 May; 40(4):1140-4. PubMed ID: 18555134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analysis of serum marker proteins in recipient mice with liver cirrhosis after bone marrow cell transplantation.
    Yokoyama Y; Terai S; Ishikawa T; Aoyama K; Urata Y; Marumoto Y; Nishina H; Nakamura K; Okita K; Sakaida I
    Proteomics; 2006 Apr; 6(8):2564-70. PubMed ID: 16548057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy.
    Terai S; Ishikawa T; Omori K; Aoyama K; Marumoto Y; Urata Y; Yokoyama Y; Uchida K; Yamasaki T; Fujii Y; Okita K; Sakaida I
    Stem Cells; 2006 Oct; 24(10):2292-8. PubMed ID: 16778155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic potential of bone marrow stromal cells: development of in vitro co-culture and intra-portal transplantation models.
    Luk JM; Wang PP; Lee CK; Wang JH; Fan ST
    J Immunol Methods; 2005 Oct; 305(1):39-47. PubMed ID: 16150456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice.
    Higashiyama R; Inagaki Y; Hong YY; Kushida M; Nakao S; Niioka M; Watanabe T; Okano H; Matsuzaki Y; Shiota G; Okazaki I
    Hepatology; 2007 Jan; 45(1):213-22. PubMed ID: 17187438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.